WSR 10-02-080

PERMANENT RULES

DEPARTMENT OF HEALTH


(Board of Pharmacy)

[ Filed January 5, 2010, 2:26 p.m. , effective February 5, 2010 ]


     Effective Date of Rule: Thirty-one days after filing.

     Purpose: The adopted rule places carisprodol [carisoprodol] into the controlled substances Schedule IV. Local, state, and national data indicate that the drug is increasingly being abused. Placing carisoprodol in a controlled substances schedule will increase prescribers knowledge of carisoprodol as a drug of abuse, will reduce the abuse, and will increase patient safety.

     Citation of Existing Rules Affected by this Order: Amending WAC 246-887-170.

     Statutory Authority for Adoption: RCW 69.50.201.

     Other Authority: RCW 18.64.005.

      Adopted under notice filed as WSR 09-16-119 on August 4, 2009.

     A final cost-benefit analysis is available by contacting Tim S. Fuller, Department of Health, Board of Pharmacy, P.O. Box 47852, Tumwater, WA 98504-7852, phone (360) 236-4827, fax (360) 236-2901, e-mail tim.fuller@doh.wa.gov.

     Number of Sections Adopted in Order to Comply with Federal Statute: New 0, Amended 0, Repealed 0; Federal Rules or Standards: New 0, Amended 0, Repealed 0; or Recently Enacted State Statutes: New 0, Amended 0, Repealed 0.

     Number of Sections Adopted at Request of a Nongovernmental Entity: New 0, Amended 0, Repealed 0.

     Number of Sections Adopted on the Agency's Own Initiative: New 0, Amended 1, Repealed 0.

     Number of Sections Adopted in Order to Clarify, Streamline, or Reform Agency Procedures: New 0, Amended 0, Repealed 0.

     Number of Sections Adopted Using Negotiated Rule Making: New 0, Amended 0, Repealed 0;      Pilot Rule Making: New 0, Amended 0, Repealed 0; or Other Alternative Rule Making: New 0, Amended 1, Repealed 0.

     Date Adopted: September 17, 2009.

Gary G. Harris, Chair

Board of Pharmacy

OTS-2517.1


AMENDATORY SECTION(Amending WSR 98-02-084, filed 1/7/98, effective 1/7/98)

WAC 246-887-170   Schedule IV.   The board finds that the following substances have a low potential for abuse relative to substances in Schedule III and have currently accepted medical use in treatment in the United States and that the abuse of the substances may lead to limited physical dependence or psychological dependence relative to the substances in Schedule III. The board, therefore, places each of the following substances in Schedule IV.

     (a) The drugs and other substances listed in this section, by whatever official name, common or usual name, chemical name, or brand name designated, are included in Schedule IV.

     (b) Narcotic drugs. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below:

     (1) Not more than 1 milligram of difenoxin and not less than 25 micrograms of atropine sulfate per dosage unit.

     (2) Dextropropoxyphene (alpha-(+)-e-dimethylamino-1,2-diphenyl-3-methyl-2 propionoxybutane).

     (c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

     (1) Alprazolam;

     (2) Barbital;

     (3) Bromazepam;

     (4) Camazepam;

     (5) Carisoprodol;

     (6) Chloral betaine;

     (((6))) (7) Chloral hydrate;

     (((7))) (8) Chlordiazepoxide;

     (((8))) (9) Clobazam;

     (((9))) (10) Clonazepam;

     (((10))) (11) Clorazepate;

     (((11))) (12) Clotiazepam;

     (((12))) (13) Cloxazolam;

     (((13))) (14) Delorazepam;

     (((14))) (15) Diazepam;

     (((15))) (16) Estazolam;

     (((16))) (17) Ethchlorvynol;

     (((17))) (18) Ethinamate;

     (((18))) (19) Ethyl loflazepate;

     (((19))) (20) Fludiazepam;

     (((20))) (21) Flunitrazepam;

     (((21))) (22) Flurazepam;

     (((22))) (23) Halazepam;

     (((23))) (24) Haloxazolam;

     (((24))) (25) Ketazolam;

     (((25))) (26) Loprazolam;

     (((26))) (27) Lorazepam;

     (((27))) (28) Lormetazepam;

     (((28))) (29) Mebutamate;

     (((29))) (30) Medazepam;

     (((30))) (31) Meprobamate;

     (((31))) (32) Methohexital;

     (((32))) (33) Methylphenobarbital (mephobarbital);

     (((33))) (34) Midazolam;

     (((34))) (35) Nimetazepam;

     (((35))) (36) Nitrazepam;

     (((36))) (37) Nordiazepam;

     (((37))) (38) Oxazepam;

     (((38))) (39) Oxazolam;

     (((39))) (40) Paraldehyde;

     (((40))) (41) Petrichloral;

     (((41))) (42) Phenobarbital;

     (((42))) (43) Pinazepam;

     (((43))) (44) Prazepam;

     (((44))) (45) Quazepam;

     (((45))) (46) Temazepam;

     (((46))) (47) Tetrazepam;

     (((47))) (48) Triazolam;

     (((48))) (49) Zolpidem.

     (d) Fenfluramine. Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position or geometric), and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible.

     (e) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:

     (1) Cathine ((+) - norpseudoephedrine);

     (2) Diethylpropion;

     (3) Fencamfamin;

     (4) Fenproporex;

     (5) Mazindol;

     (6) Mefenorex;

     (7) Pemoline (including organometallic complexes and chelates thereof);

     (8) Phentermine;

     (9) Pipradrol;

     (10) SPA ((-)-1-dimethylamino-1, 2-dephenylethane.

     (f) Other substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts:

     (1) Pentazocine;

     (2) Butorphanol.

[98-02-084 § 246-887-170, filed 1/7/98, effective 1/7/98. Statutory Authority: RCW 18.64.005. 94-08-098, § 246-887-170, filed 4/6/94, effective 5/7/94; 92-04-029 (Order 239B), § 246-887-170, filed 1/28/92, effective 2/29/92. Statutory Authority: RCW 18.64.005 and chapter 18.64A RCW. 91-18-057 (Order 191B), recodified as § 246-887-170, filed 8/30/91, effective 9/30/91. Statutory Authority: RCW 69.50.201. 89-17-023 (Order 226), § 360-36-440, filed 8/8/89, effective 9/8/89. Statutory Authority: RCW 69.50.201, 69.50.203, 69.50.205, 69.50.207, 69.50.209 and 69.50.211. 84-22-062 (Order 190), § 360-36-440, filed 11/7/84.]

© Washington State Code Reviser's Office